Edition:
United States

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

5.62USD
20 Jul 2018
Change (% chg)

$-0.20 (-3.44%)
Prev Close
$5.82
Open
$5.80
Day's High
$5.85
Day's Low
$5.57
Volume
86,158
Avg. Vol
146,902
52-wk High
$9.49
52-wk Low
$1.29

Select another date:

Mon, May 14 2018

BRIEF-Galectin Therapeutics Proceeds To Phase 3 Development Of GR-MD-02 For NASH Cirrhosis

* GALECTIN THERAPEUTICS PROCEEDS TO PHASE 3 DEVELOPMENT OF GR-MD-02 FOR NASH CIRRHOSIS FOLLOWING FDA MEETING

BRIEF-Galectin Therapeutics Q1 Loss Per Share $0.12

* GALECTIN THERAPEUTICS REPORTS 2018 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

BRIEF-Galectin Therapeutics Provides Business Update

* GALECTIN THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Select another date: